CMG Pharmaceutical Co. Ltd (058820) fair value: what the stock is really worth
As of Nov 18, 2026: fair value (intrinsic value) of CMG Pharmaceutical Co. Ltd stock KRW 3,800, price KRW 3,625, upside +4.8%, quality 30 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
CMG Pharmaceutical Co. Ltd
058820 · KQThe stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range 3,625 KRW – 55,100 KRW · fair‑value band 2,850 KRW – 4,750 KRW · the 3,625 KRW price screens below the 3,800 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 16, 2026.
Every Wednesday you see whether CMG Pharmaceutical Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea.
Show moreShow less
It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis.
CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013.
CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.
Stock analysis
CMG Pharmaceutical Co. Ltd (058820) currently trades at 3,625 KRW, while our estimate is 3,800 KRW, so the stock looks roughly fairly valued today (gap 4.6%).
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: 2,850 KRW (bear) to 4,750 KRW (bull), the price of 3,625 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 30/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
CMG Pharmaceutical Co. Ltd reported revenue of 105B KRW in FY2025 versus 69.5B KRW in FY2021, a compound +10.9%/yr. Reported net income was −10.1B KRW in FY2025.
Key figures
Market cap 70.7B KRW (≈ $53.0M) Micro · P/E ratio 15.9 · P/S ratio 0.61 · EPS (TTM) 313.26 KRW · Net margin −9.6% · Return on equity 2.3% · Return on assets (EBIT) 1.1% (5-year average) · Operating margin −10.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 19 out of 100 (low confidence).
What moves the price
The share trades about 83% below its 52-week high and at its 52-week low.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 5%, 058820 screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch 058820, get fair value alerts →
Compare CMG Pharmaceutical Co. Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 607 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Price/FCF by industry
- Debt-to-equity by industry
- PEG screener for stocks with fair value
- Undervalued stocks: South Korean Stocks
- Valuation of the Korea market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.48 | $113.53 | +36% | vs 058820 |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥46.90 | ¥52.43 | +12% | vs 058820 |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,872 | ₹1,983 | +6% | vs 058820 |
| Haleon plc HLN | $9.05 | $8.47 | −6% | vs 058820 |
| Merck KGaA MRK | €149.50 | €108.83 | −27% | vs 058820 |
| Galderma Group GALD | CHF 187.55 | CHF 112.46 | −40% | vs 058820 |
| Takeda Pharmaceutical Company TAK | $21.64 | $11.23 | −48% | vs 058820 |
| Sandoz Group SDZ | CHF 81.50 | CHF 40.91 | −50% | vs 058820 |
| Teva Pharmaceutical Industries Limited TEVA | $42.62 | $20.74 | −51% | vs 058820 |
| Divi's Laboratories Limited DIVISLAB | ₹11,049 | ₹1,567 | −86% | vs 058820 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is CMG Pharmaceutical Co. Ltd (058820) overvalued or undervalued?
What is the fair value of 058820?
What is the quality score of 058820?
What is the price target for CMG Pharmaceutical Co. Ltd (058820)?
What is the CMG Pharmaceutical Co. Ltd stock forecast for 2026?
What is the revenue of CMG Pharmaceutical Co. Ltd (058820)?
What is the intrinsic value of CMG Pharmaceutical Co. Ltd (058820)?
Is CMG Pharmaceutical Co. Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 058820?
How much is CMG Pharmaceutical Co. Ltd worth?
What do the bullish and bearish scenarios say about 058820?
What is the P/E ratio of 058820?
How solid is the balance sheet of CMG Pharmaceutical Co. Ltd (058820)?
How far is 058820 from its 52-week high?
Which stocks are comparable to CMG Pharmaceutical Co. Ltd?
Is CMG Pharmaceutical Co. Ltd stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of CMG Pharmaceutical Co. Ltd (058820)?
What should I pay attention to with CMG Pharmaceutical Co. Ltd right now?
Key figures of CMG Pharmaceutical Co. Ltd
How large is the market capitalisation of CMG Pharmaceutical Co. Ltd (058820)?
What is the P/S ratio of CMG Pharmaceutical Co. Ltd (058820)?
What are the earnings per share of CMG Pharmaceutical Co. Ltd (058820)?
What is the net margin of CMG Pharmaceutical Co. Ltd (058820)?
What is the return on equity of CMG Pharmaceutical Co. Ltd (058820)?
What is the EBIT return on assets of CMG Pharmaceutical Co. Ltd (058820)?
What is the operating margin of CMG Pharmaceutical Co. Ltd (058820)?
How fast is revenue growing at CMG Pharmaceutical Co. Ltd (058820)?
How fast are earnings growing at CMG Pharmaceutical Co. Ltd (058820)?
How much free cash flow does CMG Pharmaceutical Co. Ltd (058820) generate?
How much net debt does CMG Pharmaceutical Co. Ltd (058820) carry?
Watch CMG Pharmaceutical Co. Ltd in the live analysis
One click puts CMG Pharmaceutical Co. Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.